Qianjiang Yongan Pharmaceutical Co., Ltd.

XSEC:002365 Stock Report

Market Cap: CN¥2.4b

Qianjiang Yongan Pharmaceutical Management

Management criteria checks 2/4

Qianjiang Yongan Pharmaceutical's CEO is Rengui Hong, appointed in Jun 2021, has a tenure of 3.42 years. directly owns 0.062% of the company’s shares, worth CN¥1.49M. The average tenure of the management team and the board of directors is 8.8 years and 3.4 years respectively.

Key information

Rengui Hong

Chief executive officer

CN¥1.9m

Total compensation

CEO salary percentagen/a
CEO tenure3.4yrs
CEO ownership0.06%
Management average tenure8.8yrs
Board average tenure3.4yrs

Recent management updates

Recent updates


CEO

Rengui Hong (41 yo)

3.4yrs

Tenure

CN¥1,909,100

Compensation

Mr. Rengui Hong is Managing Director and Director of Qianjiang Yongan Pharmaceutical Co. Ltd. from June 28, 2021.


Leadership Team

NamePositionTenureCompensationOwnership
Rengui Hong
MD & Director3.4yrsCN¥1.91m0.062%
CN¥ 1.5m
Baineng Luo
Head of the Audit Department8.2yrsCN¥522.50k0.062%
CN¥ 1.5m
Shi Hao Dong
Deputy General Manager18.7yrsCN¥1.09m0.37%
CN¥ 9.0m
Xiquan Fang
Deputy General Manager11.3yrsCN¥1.74m0.097%
CN¥ 2.3m
Zhihua Wang
Deputy General Manager9.4yrsCN¥918.30k0.097%
CN¥ 2.3m
Shaobo Li
Senior Management5.8yrsCN¥627.70k0.017%
CN¥ 409.9k

8.8yrs

Average Tenure

53.5yo

Average Age

Experienced Management: 002365's management team is seasoned and experienced (8.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Rengui Hong
MD & Director3.4yrsCN¥1.91m0.062%
CN¥ 1.5m
Yong Chen
Chairman18.7yrsCN¥2.95m21.79%
CN¥ 525.5m
Yuxi Wu
Chairman of the Supervisory Board3.4yrsCN¥166.70k0.19%
CN¥ 4.6m
Chunxiang Zhao
Independent Director3.4yrsCN¥80.00kno data
Bing Zhang
Independent Director3.4yrsCN¥80.00kno data
Xu Wu
Supervisor9.4yrsno datano data
Zidi Chen
Non-Independent Directorless than a yearCN¥367.60kno data
Wen Chen
Independent Directorless than a yearno datano data

3.4yrs

Average Tenure

46yo

Average Age

Experienced Board: 002365's board of directors are considered experienced (3.4 years average tenure).